• Cryptocurrency that Cares

    I interviewed the top minds in the Bitcoin world about how nonprofits can benefits from this digital currency. Click here to learn more.

  • Writing and Publications

    Digital Strategy, Innovation, Co-Creation, Crowdfunding, Nonprofits, Volunteerism, Advocate Programs and Bitcoin are my passions. I often get to write about them. Click here to read more.

  • Speaking

    I've been keynoting and speaking at a variety of conferences for the last eight years. I'd love to hear more about yours. Click here to learn more.

Creativity & Innovation

Creativity & Innovation: New ideas, products, concepts, ideation. IdeaFlow – Corante. If innovation is your thing, you might check-out this index to posts about the Innovation Convergence conference that was held in Minnesota a couple of weeks ago. The event was covered by authors of the Corante blog “Idea Flow.” There are some interesting ideas salted away in their reports.

Read More »

In-kind donations

The McKinsey Quarterly: In-kind donations for nonprofits Here’s a rather interesting article about in-kind donations written by a publication that is primarily business-oriented. It has a useful model of the process of developing an in-kind donations approach. It also mentions the ACS.

Read More »

Keeping up

Another week, another conference (in Boston) about the offshoring crisis in IT and what to do about it. The interesting nuance to this one is the admonition to IT professionals to invest in training whether they are unemployed or employed and to be ready to shift careers. So the admonitions that started a couple of decades ago about “lifelong learning” ...

Read More »

Financing future health care

The earlier post, “At what price?”, raised an interesting issue about the cost of cancer therapies that extend life at significant financial and social cost. It echoes a view expressed recently in an article entitled, “Aging Gracelessly: Can the US devise a rational economic model for health care?” It appeared in Acumen: Journal of the Life Sciences.

Read More »